These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 3666712)
1. Promoting compliance with outpatient drug treatment. Frances A; Weiden P Hosp Community Psychiatry; 1987 Nov; 38(11):1158-60. PubMed ID: 3666712 [No Abstract] [Full Text] [Related]
2. Ethopropazine and benztropine in neuroleptic-induced parkinsonism. Chouinard G; Annable L; Ross-Chouinard A; Kropsky ML J Clin Psychiatry; 1979 Mar; 40(3):147-52. PubMed ID: 33969 [TBL] [Abstract][Full Text] [Related]
3. The diagnosis of rapid abnormal involuntary movements associated with fluphenazine decanoate. Glazer WM; Moore DC J Nerv Ment Dis; 1980 Jul; 168(7):439-41. PubMed ID: 7400795 [TBL] [Abstract][Full Text] [Related]
4. The effects of a drug holiday on relapse and tardive dyskinesia in chronic schizophrenics [proceedings]. Goldberg SC; Shenoy RS; Sadler A; Hamer R; Ross B Psychopharmacol Bull; 1981 Jan; 17(1):116-7. PubMed ID: 7232638 [No Abstract] [Full Text] [Related]
5. Fluphenazine and tardive dyskinesia. Perényi A; Arató M Arch Gen Psychiatry; 1984 Jul; 41(7):727. PubMed ID: 6732436 [No Abstract] [Full Text] [Related]
6. Psychotic symptoms preceding ocular deviation in a patient with tardive oculogyric crises. Sachdev P; Tang WM Aust N Z J Psychiatry; 1992 Dec; 26(4):666-70. PubMed ID: 1362053 [TBL] [Abstract][Full Text] [Related]
8. Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate. Gelenberg AJ; Doller JC; Schooler NR; Mieske M; Severe J; Mandel MR Am J Psychiatry; 1979 Feb; 136(2):217-9. PubMed ID: 367182 [No Abstract] [Full Text] [Related]
9. The use of fluphenazines in a continuing-care program. Owens D Hosp Community Psychiatry; 1978 Feb; 29(2):115-8. PubMed ID: 620998 [TBL] [Abstract][Full Text] [Related]
10. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study. Levine J; Schooler NR; Severe J; Escobar J; Gelenberg A; Mandel M; Sovner R; Steinbook R Adv Biochem Psychopharmacol; 1980; 24():483-93. PubMed ID: 6996445 [No Abstract] [Full Text] [Related]
12. Fluphenazine decanoate, fluphenazine hydrochloride given orally, and placebo in remitted schizophrenics. I. Relapse rates after one year. Rifkin A; Quitkin F; Rabiner CJ; Klein DF Arch Gen Psychiatry; 1977 Jan; 34(1):43-7. PubMed ID: 189724 [TBL] [Abstract][Full Text] [Related]
14. Tardive dyskinesia and current dose of neuroleptic drugs. Kolakowska T; Williams AO; Ardern M Arch Gen Psychiatry; 1985 Sep; 42(9):925. PubMed ID: 2864034 [No Abstract] [Full Text] [Related]